Radioiodine remnant ablation of differentiated thyroid cancer does not further increase oxidative damage to membrane lipids - early effect

INTRODUCTION: Radioiodine ((131)I) therapy is widely accepted as an essential part of therapeutic regimens in many cases of differentiated thyroid cancer. Radiation-induced oxidative damage to macromolecules is a well known phenomenon. Frequently examined process to evaluate oxidative damage to macr...

Descripción completa

Detalles Bibliográficos
Autores principales: Makarewicz, Jacek, Lewiński, Andrzej, Karbownik-Lewińska, Małgorzata
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2964524/
https://www.ncbi.nlm.nih.gov/pubmed/20925955
http://dx.doi.org/10.1186/1756-6614-3-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2964524/
https://www.ncbi.nlm.nih.gov/pubmed/20925955
http://dx.doi.org/10.1186/1756-6614-3-7

Ejemplares similares